Isolation of human lymphatic endothelial cells by multi-parameter fluorescence-activated cell sorting

Area of Science:

• Vascular Biology
• Cell Biology
• Regenerative Medicine

Background:

• Lymphatic system disorders, including primary lymphedema, lymphatic malformations, and tumors, are rare but cause significant illness.
• The underlying biology of these lymphatic disorders is poorly understood.
• Isolating pure human lymphatic endothelial cells (LECs) from both healthy and diseased tissues is crucial for advancing research.

Purpose of the Study:

• To present a reliable protocol for isolating pure human lymphatic endothelial cells (LECs).
• To enable genetic, molecular, and cellular studies of the lymphatic endothelium.
• To identify potential therapeutic targets for lymphatic disorders.

Main Methods:

• A protocol was developed for isolating human foreskin LECs and lymphatic malformation LECs (LM LECs).
• Tissue was minced and enzymatically digested using dispase II and collagenase II to create a single-cell suspension.
• Fluorescence-activated cell sorting (FACS) was used with specific cluster of differentiation (CD) markers (CD34, CD31, VEGFR-3, PODOPLANIN) to isolate LM LECs.

Main Results:

• A pure population of lymphatic endothelial cells (LECs) from lymphatic malformations was successfully isolated using the described protocol.
• The isolated LM LECs were characterized by specific marker expression: CD34(Low)CD31(Pos)VEGFR-3(Pos)PODOPLANIN(Pos).
• The sorted LM LECs were cultured and expanded for subsequent experimental investigations.

Conclusions:

• The presented protocol provides a method for obtaining highly pure human lymphatic endothelial cells (LECs) from lymphatic malformations.
• This isolation technique will facilitate in-depth studies into the biology of lymphatic endothelial cells.
• The research is expected to contribute to the development of novel therapies for rare lymphatic system disorders.